লোডিং...
Alternative Facts and the ICER Proposed Policy on Access to Imaginary Pharmacoeconomic Worlds
The Institute for Clinical and Economic Review (ICER) announced at the end of March 2018 that it proposed to share executable draft economic models with relevant drug manufacturers during ICER evidence reviews. Taken at face value, ICER is offering manufacturers and other interested parties the poss...
সংরক্ষণ করুন:
| প্রকাশিত: | Innov Pharm |
|---|---|
| প্রধান লেখক: | |
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
University of Minnesota Libraries Publishing
2018
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6438559/ https://ncbi.nlm.nih.gov/pubmed/34007702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.24926/iip.v9i2.1300 |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|